ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04064	NF-kappa B signaling pathway	13/140	96/7206	3.26586694947e-08
ko04657	IL-17 signaling pathway	12/140	87/7206	9.19599443538e-08
ko04668	TNF signaling pathway	12/140	120/7206	3.16206826665e-06
ko04621	NOD-like receptor signaling pathway	13/140	157/7206	9.9815652812e-06
ko05212	Pancreatic cancer	9/140	83/7206	2.95866922849e-05
ko04622	RIG-I-like receptor signaling pathway	7/140	62/7206	0.000181240695938
ko05200	Pathways in cancer	22/140	492/7206	0.000228430767814
ko05222	Small cell lung cancer	8/140	89/7206	0.000311792027211
ko00590	Arachidonic acid metabolism	6/140	52/7206	0.000471576633264
ko05162	Measles	9/140	120/7206	0.00051280276635
ko05161	Hepatitis B	11/140	173/7206	0.000515516943902
ko04660	T cell receptor signaling pathway	9/140	124/7206	0.00065173395899
ko04620	Toll-like receptor signaling pathway	8/140	100/7206	0.000686878022393
ko05145	Toxoplasmosis	9/140	126/7206	0.00073195684907
ko05202	Transcriptional misregulation in cancer	11/140	188/7206	0.00103121929372
ko04380	Osteoclast differentiation	9/140	134/7206	0.0011375975994
ko05215	Prostate cancer	8/140	111/7206	0.00136303998132
ko04662	B cell receptor signaling pathway	7/140	88/7206	0.00153896521317
ko04624	Toll and Imd signaling pathway	5/140	49/7206	0.00247278748109
ko01523	Antifolate resistance	4/140	30/7206	0.0025260979852
ko04658	Th1 and Th2 cell differentiation	7/140	96/7206	0.00254127272032
ko04210	Apoptosis	10/140	180/7206	0.002557974833
ko04214	Apoptosis - fly	6/140	72/7206	0.00263563342523
ko05160	Hepatitis C	9/140	153/7206	0.00284813509164
ko00564	Glycerophospholipid metabolism	7/140	99/7206	0.00302501475923
ko05146	Amoebiasis	7/140	99/7206	0.00302501475923
ko05140	Leishmaniasis	6/140	75/7206	0.00323953919151
ko05152	Tuberculosis	10/140	187/7206	0.00337226058098
ko05167	Kaposi's sarcoma-associated herpesvirus infection	10/140	191/7206	0.00392301158008
ko04659	Th17 cell differentiation	7/140	106/7206	0.00442692851438
ko04931	Insulin resistance	8/140	137/7206	0.00506413376312
ko05220	Chronic myeloid leukemia	6/140	85/7206	0.00600994164006
ko00600	Sphingolipid metabolism	5/140	63/7206	0.00734269206714
ko05206	MicroRNAs in cancer	9/140	177/7206	0.00739072712799
ko04217	Necroptosis	9/140	178/7206	0.00765879432846
ko04623	Cytosolic DNA-sensing pathway	4/140	41/7206	0.00791876048042
ko00565	Ether lipid metabolism	4/140	42/7206	0.00862287798948
ko00531	Glycosaminoglycan degradation	3/140	23/7206	0.00956288231928
ko05132	Salmonella infection	6/140	98/7206	0.0117932918976
ko04151	PI3K-Akt signaling pathway	15/140	390/7206	0.0119922096957
ko05142	Chagas disease (American trypanosomiasis)	7/140	130/7206	0.0130869485107
ko00511	Other glycan degradation	3/140	26/7206	0.013457883446
ko05219	Bladder cancer	4/140	48/7206	0.0137109347156
ko00512	Mucin type O-glycan biosynthesis	3/140	29/7206	0.0181325101288
ko05169	Epstein-Barr virus infection	9/140	206/7206	0.0186333424905
ko00944	Flavone and flavonol biosynthesis	1/140	1/7206	0.0194282542326
ko05203	Viral carcinogenesis	11/140	277/7206	0.0225928663025
ko04015	Rap1 signaling pathway	11/140	278/7206	0.0229673588287
ko05321	Inflammatory bowel disease (IBD)	4/140	56/7206	0.0229914315231
ko04014	Ras signaling pathway	11/140	279/7206	0.0233516038287
ko04144	Endocytosis	13/140	342/7206	0.0236804264238
ko04142	Lysosome	7/140	151/7206	0.0273906882495
ko05166	HTLV-I infection	11/140	292/7206	0.0292578568439
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/140	92/7206	0.0329745432661
ko05221	Acute myeloid leukemia	4/140	63/7206	0.0336358580746
ko04722	Neurotrophin signaling pathway	7/140	160/7206	0.0359282091957
ko00073	Cutin, suberine and wax biosynthesis	1/140	2/7206	0.038481695511
ko04933	AGE-RAGE signaling pathway in diabetic complications	6/140	135/7206	0.0473212402688